• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form POS AM filed by Manning & Napier Inc.

    10/27/22 4:27:01 PM ET
    $MN
    Investment Managers
    Finance
    Get the next $MN alert in real time by email
    POS AM 1 d381738dposam.htm POS AM POS AM

    As filed with the Securities and Exchange Commission on October 27, 2022

    Registration No. 333-260193

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    POST-EFFECTIVE AMENDMENT NO. 1 TO

    FORM S-3

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

     

    MANNING & NAPIER, INC.

    (Exact Name of Registrant as Specified in Its Charter)

     

     

     

    Delaware   45-2609100
    (State or Other Jurisdiction of
    Incorporation or Organization)
      (I.R.S. Employer
    Identification Number)

    290 Woodcliff Drive

    Fairport, NY 14450

    (585) 325-6880

    (Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)

     

     

    Sarah C. Turner

    Corporate Secretary

    Manning & Napier, Inc.

    290 Woodcliff Drive, Fairport, NY 14450

    (585) 325-6880

    (Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service)

     

     

    Approximate date of commencement of proposed sale to the public: Not applicable.

    If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box.  ☐

    If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box.  ☐

    If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ☐

    If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ☐

    If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box.  ☐

    If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.  ☐

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer   ☐    Accelerated filer   ☒
    Non-accelerated filer   ☐    Smaller reporting company   ☒
         Emerging growth company   ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  ☐

     

     

     


    EXPLANATORY NOTE - DEREGISTRATION OF SECURITIES

    This post-effective amendment relates to the Registration Statement on Form S-3 (Registration Statement No. 333-260193) (the “Registration Statement”), filed by Manning & Napier, Inc. (the “Company”) with the Securities and Exchange Commission on October 12, 2021, registering up to an aggregate of 1,127,088 shares of the Company’s Common Stock, for resale by the selling stockholders named therein.

    This post-effective amendment to the Registration Statement is being filed in order to deregister all shares of Common Stock that were registered under the Registration Statement and remain unissued, if any.

    On October 21, 2022, the Company merged with and into Callodine Merger Sub, Inc. and became a wholly-owned subsidiary of Callodine Midco, Inc. As a result of the merger, the Company has terminated any and all offerings of the Company’s securities pursuant to its existing registration statements under the Securities Act of 1933, as amended, including the Registration Statement. The Company has no further obligation to maintain effectiveness of the Registration Statement, and the Company wishes to discontinue the effectiveness of the Registration Statement. Accordingly, this Post-Effective Amendment No. 1 is being filed to terminate the effectiveness of the Registration Statement and to remove from registration all securities registered but not sold under the Registration Statement.


    SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this post-effective amendment to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Fairport, State of New York, on October 26, 2022.

     

    MANNING & NAPIER, INC.
    By:  

    /s/ Marc Mayer

      Marc Mayer
      Chief Executive Officer

    Pursuant to the requirements of the Securities Act of 1933, as amended, this post-effective amendment to the Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

     

    SIGNATURE      TITLE   DATE

    /s/ Marc Mayer

    Marc Mayer

         Chief Executive Officer and Director
    (principal executive officer)
      October 26, 2022

    /s/ Paul J. Battaglia

    Paul J. Battaglia

         Chief Financial Officer
    (principal financial and accounting officer)
      October 26, 2022

    /s/ James Morrow

    James Morrow

         Director   October 26, 2022

    /s/ Austin McClintock

    Austin McClintock

         Director   October 26, 2022

    /s/ Tyler Bak

    Tyler Bak

         Director   October 26, 2022

    /s/ Adam Gusky

    Adam Gusky

         Director  

    October 26, 2022

    Get the next $MN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Callodine Group Completes Take Private Acquisition of Manning & Napier, Inc.

      FAIRPORT, N.Y., Oct. 21, 2022 /PRNewswire/ -- Manning & Napier, Inc. (NYSE:MN), ("Manning & Napier" or "the Company") today announced the completion of its process to go private and be acquired by Callodine Group LLC ("Callodine"), a Boston-based asset management firm. The transaction was announced on April 1, 2022 and received shareholder approval on August 3, 2022. Under the terms of the go-private transaction, Manning & Napier stockholders will receive $12.85 per share in cash. With the completion of the acquisition, Manning & Napier's common stock has ceased trading and will no longer be listed on the New York Stock Exchange. "We are excited to complete the acquisition of Manning & Napie

      10/21/22 8:58:00 AM ET
      $MN
      Investment Managers
      Finance
    • Manning & Napier, Inc. Reports September 30, 2022 Assets Under Management

      FAIRPORT, N.Y., Oct. 12, 2022 /PRNewswire/ -- Manning & Napier, Inc. (NYSE:MN), ("Manning & Napier" or "the Company") today reported preliminary assets under management ("AUM") as of September 30, 2022 of $17.4 billion, which included approximately $12.4 billion in separately managed accounts and approximately $5.0 billion in mutual funds and collective investment trusts. Transaction Update As previously announced, Manning & Napier expects to complete its transaction with Callodine Group in October 2022. About Manning & Napier, Inc. Manning & Napier (NYSE:MN) provides a broad range of investment solutions through separately managed accounts, mutual funds, and collective investment trust fund

      10/12/22 4:05:00 PM ET
      $MN
      Investment Managers
      Finance
    • Manning & Napier, Inc. Transaction Update

      FAIRPORT, N.Y., Sept. 28, 2022 /PRNewswire/ -- Manning & Napier, Inc. (NYSE:MN), ("Manning & Napier" or "the Company") today announced the extension of the outside date under the merger agreement with Callodine Group LLC ("Callodine") to December 1, 2022. "We continue to work diligently to conclude the regulatory review processes necessary to close our transaction," said Marc Mayer, Chairman and CEO of Manning & Napier. "In order to continue to productively engage with the regulators, we have revised our outlook and now expect the transaction to close in October 2022. We appreciate the continued support of our employees, clients and shareholders and look forward to the Company's next chapter

      9/28/22 4:05:00 PM ET
      $MN
      Investment Managers
      Finance

    $MN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Goodstein Barbara returned $2,285,347 worth of shares to the company (177,848 units at $12.85), closing all direct ownership in the company

      4 - Manning & Napier, Inc. (0001524223) (Issuer)

      10/26/22 4:48:22 PM ET
      $MN
      Investment Managers
      Finance
    • SEC Form 4: Pettinella Edward J returned $6,930,236 worth of shares to the company (539,318 units at $12.85), closing all direct ownership in the company

      4 - Manning & Napier, Inc. (0001524223) (Issuer)

      10/26/22 4:46:23 PM ET
      $MN
      Investment Managers
      Finance
    • SEC Form 4: Marvald Kenneth A returned $1,682,913 worth of shares to the company (130,966 units at $12.85), closing all direct ownership in the company

      4 - Manning & Napier, Inc. (0001524223) (Issuer)

      10/26/22 4:45:40 PM ET
      $MN
      Investment Managers
      Finance

    $MN
    Financials

    Live finance-specific insights

    See more
    • Manning & Napier, Inc. Reports Second Quarter 2022 Earnings Results

      FAIRPORT, N.Y., Aug. 9, 2022 /PRNewswire/ -- Manning & Napier, Inc. (NYSE:MN), ("Manning & Napier" or the "Company") today reported 2022 second quarter results for the period ended June 30, 2022. "Broad and significant declines across capital markets globally continued in the second quarter, pressuring revenues and causing mark-to-market declines in securities held on the balance sheet," commented Marc Mayer, Chairman of the Board and Chief Executive Officer of Manning & Napier. "We are managing our expenses thoughtfully and we are entirely focused on delivering excellent results and superior service for our clients." Mr. Mayer added, "We are progressing toward the completion of our previous

      8/9/22 8:00:00 AM ET
      $MN
      Investment Managers
      Finance
    • Manning & Napier, Inc. Announces Quarterly Dividend

      FAIRPORT, N.Y., July 22, 2022 /PRNewswire/ -- Manning & Napier, Inc. (NYSE:MN), ("Manning & Napier" or "the Company") today announced that its Board of Directors has declared a quarterly dividend of $0.05 per share of Class A common stock. The dividend will be paid on or about August 19, 2022 to shareholders of record as of the close of business on August 5, 2022.  About Manning & Napier, Inc.Manning & Napier (NYSE:MN) provides a broad range of investment solutions through separately managed accounts, mutual funds, and collective investment trust funds, as well as a variety of consultative services that complement our investment process. Founded in 1970, we offer equity, fixed income and alt

      7/22/22 8:00:00 AM ET
      $MN
      Investment Managers
      Finance
    • Manning & Napier, Inc. to Report Second Quarter Results; Announces June 30, 2022 Assets Under Management

      FAIRPORT, N.Y., July 13, 2022 /PRNewswire/ -- Manning & Napier, Inc. (NYSE:MN), ("Manning & Napier" or "the Company") today announced that it expects to release its second quarter 2022 financial results the week of August 8th, 2022, in conjunction with its related 10-Q filing. In light of the previously announced definitive agreement to be acquired by Callodine Group, the Company will not host a conference call to discuss second quarter 2022 financial results. Assets Under ManagementThe Company also announced that preliminary June 30, 2022 assets under management ("AUM") were $18.5 billion, which included approximately $13.3 billion in separately managed accounts and approximately $5.2 billi

      7/13/22 4:05:00 PM ET
      $MN
      Investment Managers
      Finance

    $MN
    SEC Filings

    See more

    $MN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form EFFECT filed by Manning & Napier Inc.

      EFFECT - Manning & Napier, Inc. (0001524223) (Filer)

      11/1/22 12:15:07 AM ET
      $MN
      Investment Managers
      Finance
    • SEC Form 15-12G filed by Manning & Napier Inc.

      15-12G - Manning & Napier, Inc. (0001524223) (Filer)

      10/31/22 4:01:31 PM ET
      $MN
      Investment Managers
      Finance
    • SEC Form S-8 POS filed by Manning & Napier Inc.

      S-8 POS - Manning & Napier, Inc. (0001524223) (Filer)

      10/27/22 4:31:58 PM ET
      $MN
      Investment Managers
      Finance
    • SEC Form SC 13G/A filed by Manning & Napier Inc. (Amendment)

      SC 13G/A - Manning & Napier, Inc. (0001524223) (Subject)

      2/13/23 12:54:51 PM ET
      $MN
      Investment Managers
      Finance
    • SEC Form SC 13D/A filed by Manning & Napier Inc. (Amendment)

      SC 13D/A - Manning & Napier, Inc. (0001524223) (Subject)

      10/26/22 3:56:32 PM ET
      $MN
      Investment Managers
      Finance
    • SEC Form SC 13G/A filed by Manning & Napier Inc. (Amendment)

      SC 13G/A - Manning & Napier, Inc. (0001524223) (Subject)

      6/8/22 10:44:24 AM ET
      $MN
      Investment Managers
      Finance

    $MN
    Leadership Updates

    Live Leadership Updates

    See more
    • Lakeland Industries Appoints Investment Industry Veteran Nikki Hamblin to Board of Directors

      DECATUR, AL / ACCESSWIRE / February 24, 2021 / Lakeland Industries, Inc. (NASDAQ:LAKE) (the "Company" or "Lakeland"), a leading global manufacturer of protective clothing for industry, healthcare and to first responders on the federal, state and local levels, today announced the appointment of investment industry veteran Nikki Hamblin to its Board of Directors (the "Board"). The appointment increases the number of directors to seven, five of whom are independent. Christopher J. Ryan, Executive Chairman of Lakeland Industries, commented, "We are pleased to have Nikki join our Board to enhance our sound governance and solid succession planning. Her appointment and the increased size of our Bo

      2/24/21 9:00:00 AM ET
      $MN
      $LAKE
      Investment Managers
      Finance
      Industrial Specialties
      Health Care